碳烯预授权的长期影响:20年间的中断时间序列研究
1Division of Infectious Disease and Hospital Epidemiology, Saga University Hospital, Saga, Japan.
The Journal of hospital infection
|June 26, 2025
概括
在过去的20年里,碳烯的预先授权有效地减少了过度使用. 这一策略被证明是安全的,没有对医院流行病学或死亡率产生不利影响.
科学领域:
- 传染性疾病 传染性疾病
- 医院流行病学 医院流行病学
- 抗微生物药物管理委员会
背景情况:
- 过度使用卡巴是医疗保健机构的一个重大问题.
- 关于碳烯限制策略有效性的长期数据有限.
研究的目的:
- 通过事先授权评估碳烯限制的长期影响.
- 评估近二十年来对抗微生物药物使用密度 (AUD),死亡率和抗生素耐药性的影响.
主要方法:
- 间断时间序列 (ITS) 分析,比较干预前 (2004-2005) 和干预 (2006-2023) 期间.
- 检查了卡巴胺AUD,28天内死于医院细菌病的死亡率,以及耐药病原体的流行率.
主要成果:
- 预审后卡巴胺AUD显著减少 (水平变化P=0.002,趋势转变P=0.048).
- 由于医院内细菌病的28天死亡率没有增加.
- 在卡巴胺AUD和MRSA,抗美罗胺P.aeruginosa和A.baumannii的流行率之间发现了积极的相关性.
结论:
- 长期的碳烯预授权有效地减少了抗微生物药物的使用.
- 该战略在20年内没有对医院流行病学产生不利影响.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.0K
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.8K
相关概念视频
Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
Antimicrobial Effectiveness
175
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
175
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
229
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
229
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Analysis of Population Pharmacokinetic Data
396
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
396
Development of Antibiotic Resistance
220
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
220
